Answers are grounded in this paper and cite their sources.
We report the development of BioPhysical and Active Learning Screening ( BioP ALS ); a rapid and versatile hit identification protocol combining AI‐powered virtual screening with a GCI‐driven biophysical confirmation workflow. Its application to the BRPF1b bromodomain afforded a range of novel micromolar binders with favorable ADMET properties. In addition to the excellent in silico/in vitro confirmation rate demonstrated with BRPF1b, binding kinetics were determined, and binding topologies predicted for all hits. BioP ALS is a lean, data‐rich, and standardized approach to hit identification applicable to a wide range of biological targets.
No takes yet. Share an insight, caveat, or question.
Pal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: